Atlas Merchant Capital’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-325,000
Closed -$3.26M 161
2022
Q4
$3.26M Buy
+325,000
New +$3.23M 0.53% 65

Other funds holding AONC

Atlas Merchant Capital's AONC Position: Q1 2023 in Review

Atlas Merchant Capital sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 325,000 shares — an estimated $3.26M sold.

Atlas Merchant Capital first reported a position in AONC in Q4 2022 and held it in 1 quarter. The position peaked at $3.26M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Atlas Merchant Capital reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Atlas Merchant Capital sold 325,000 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $3.26M.
  • Atlas Merchant Capital first reported a position in American Oncology Network, Inc. Class A Common Stock in Q4 2022 and held it in 1 quarter.
  • Atlas Merchant Capital's American Oncology Network, Inc. Class A Common Stock position peaked at $3.26M in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Atlas Merchant Capital's 13F filing for Q1 2023, filed 15 May 2023.